SCHEMBL30879176

SCHEMBL30879176

CSc1ncc2c(n1)N(C)C(=O)C(Cc1ccccc1)C2=O

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CES2 O00748 4/20 0.39
MAPT P10636 2/20 0.38
SLC6A2 P23975 5/20 0.36
CACNA2D1 P54289 5/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36
THRB P10828 1/20 0.35
HSD17B10 Q99714 1/20 0.35
EP300 Q09472 1/20 0.35
CCNA2 P20248 1/20 0.34
CDK2 P24941 1/20 0.34
PDE5A O76074 1/20 0.34
FGFR4 P22455 1/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30879301 0.80 MAPT (0.37) MEN1KMT2AMAPTSLC6A2CACNA2D1
SCHEMBL30879246 0.75 FGFR4 (0.36) MEN1KMT2AMAPTKDM4EFGFR4
SCHEMBL30879072 0.74 STK4 (0.38) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL30878982 0.72 RPS6KA5 (0.37) MEN1KMT2AMAPTKDM4EHPGD
SCHEMBL17070921 0.70 KDM4E (0.69) KDM4CMEN1KMT2ACES2ALDH1A1
SCHEMBL30879206 0.69 FGFR4 (0.40) MEN1KMT2AMAPTSLC6A2CACNA2D1
SCHEMBL7590747 0.68 MAPT (0.36) MEN1KMT2AMAPTSLC6A2CACNA2D1
SCHEMBL4435666 0.66 KMT2A (0.72) KDM4CMEN1KMT2ACES2MAPT
SCHEMBL27265278 0.65 FGFR4 (0.53) MAPTSLC6A2CACNA2D1ALDH1A1KDM4E
SCHEMBL3528616 0.65 SLC6A2 (0.41) MEN1KMT2AMAPTSLC6A2CACNA2D1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO disclosed